INS and type 1 diabetes mellitus: The objectives of our GLUREDIA study were to characterize PHH events in a cohort of pediatric patients with new-onset type 1 diabetes and investigate whether PHH parameters correlated with glycemic homeostasis including clinical parameters (e.g., Glycated hemoglobin [HbA1C], total daily dose of insulin [TDD], Insulin-Dose Adjusted A1C [IDAA1C]), continuous glucose monitoring metrics or residual β-cell secretion (i.e., estimated c-peptide [CPEPEST]).